The preventable burden of pneumococcal disease in the developing world
Abstract
The efficacy of pneumococcal conjugate vaccines (PCV) and their remarkable success in operational use in North America challenge us to define the burden of pneumococcal disease and the likely benefits of PCV use in developing countries. Community-based incidence studies of invasive pneumococcal dise …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
Child
Infant
newborn
preschool
vaccines
pmid:17028081
doi:10.1016/j.vaccine.2006.09.008
j a g scott
developing countries
pneumococcal infections / epidemiology*
pneumococcal infections / mortality
pneumococcal infections / prevention & control*
pneumococcal vaccines / immunology
pneumococcal vaccines / therapeutic use*
conjugate / immunology
conjugate / therapeutic use
Access
Citation
ID:
111098
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
111098
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet